Almaty City Emergency Hospital has unveiled an innovative Alzheimer's disease treatment using the NEUROLITH device, reports profit.kz.
Kazakhstan will become the first country in Central Asia to introduce this technology into medical practice. Neurologists and neurosurgeons at the city emergency hospital are currently undergoing training on the new equipment.
The device, developed by Swiss company Storz Medical, is designed for non-invasive transcranial pulsed stimulation of the brain — a safe, painless method that uses magnetic or electrical impulses applied through the scalp.
During the procedure, acoustic impulses target specific brain regions. Precise targeting is achieved using 3D navigation based on the patient's MRI scans.
The technology has been used in Europe since 2018. According to the developers, over 20,000 patients have already undergone treatment.
A standard course consists of roughly six half-hour sessions over two weeks. No serious side effects have been reported during its use.
The device cannot cure the disease entirely, but its use may help improve patients' quality of life and alleviate symptoms.
Early signs of Alzheimer's disease can be detected through a simple blood test — more details in the Kursiv Health article.